|
000
| 01916cam 2200277za 4500 |
|---|
| 001 | 9.823774 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107143955 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 160908s2010 onc |o f|0| 0 eng d |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH14-201/2010E-PDF |
|---|
| 245 | 00|aNational Anti-Drug Strategy (NADS) Implementation Evaluation |h[electronic resource] : |bfinal report. |
|---|
| 260 | |a[Ottawa] : |bHealth Canada, |c2010. |
|---|
| 300 | |a[62] p. in various pagings |
|---|
| 500 | |a"March 24, 2010." |
|---|
| 500 | |a"Approved by Senior Management Board Finance, Evaluation and Accountability (SMB-FEA) Health Canada." |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 520 | |aThe National Anti-Drug Strategy (the “Strategy”) is a horizontal initiative of 12 federal departments and agencies, led by the Department of Justice Canada (DOJ). As described in the Speech from the Throne in October 2007, the Strategy is a focused initiative whose goal is to “contribute to safer and healthier communities through coordinated efforts to prevent use, treat dependency and reduce production and distribution of illicit drugs.”1 The Strategy seeks to achieve this goal through three action plans devoted to prevention, treatment, and enforcement. The Implementation Evaluation of the Strategy was conducted between December 2008 and September 2009 in accordance with Treasury Board requirements. The primary purpose of the evaluation was to assess whether the Strategy has been implemented as planned. This report summarizes the evaluation findings, draws conclusions, and provides recommendations. |
|---|
| 692 | 07|2gccst|aDrug use |
|---|
| 692 | 07|2gccst|aDrug addiction |
|---|
| 692 | 07|2gccst|aPrevention |
|---|
| 692 | 07|2gccst|aProgram assessment |
|---|
| 710 | 1 |aCanada. |bHealth Canada. |
|---|
| 856 | 40|qPDF|s292 KB|uhttps://publications.gc.ca/collections/collection_2016/sc-hc/H14-201-2010-eng.pdf |
|---|